• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Openwater Secures $100M to Tackle Diseases at the Cellular Level

by Fred Pennic 08/22/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Openwater, a pioneering healthcare technology company, today announced the acceleration of its plans to commercialize its groundbreaking platform that leverages semiconductor physics, light, and sound to diagnose and treat diseases at the cellular level.

– Founded by Mary Lou Jepsen, a former executive at Google X, Meta, and “One Laptop Per Child,” Openwater has secured $100M in funding to advance its mission of making advanced medical care accessible worldwide. The investment round was backed by prominent investors including Plum Alley Ventures, Khosla Ventures, BOLD Capital Partners, Esther Dyson, and Peter Gabriel.

Fighting Disease with Technology

Openwater’s innovative platform combines high-resolution infrared imaging, precision-tuned ultrasound, and targeted electromagnetic fields to enable unprecedented visualization, monitoring, and treatment of biological issues. This unique approach offers the potential to revolutionize healthcare by providing more accurate diagnoses, targeted therapies, and improved patient outcomes.

Key features of the platform include: 

  • Precision and selectivity: The platform can selectively destroy cancer cells while leaving healthy cells unaffected, similar to the precision of an opera singer’s voice shattering a specific wine glass.
  • Versatility: Preclinical and clinical studies have demonstrated the technology’s potential across various medical fields, including oncology, neurology, and ophthalmology.
  • Open-source approach: By adopting an open-source model, Openwater aims to accelerate medical innovation and reduce the time and cost associated with bringing new medical devices to market.

Addressing Global Healthcare Challenges

Openwater’s technology has the potential to address several critical challenges facing the healthcare industry:

  • Accessibility: The company’s focus on affordability and accessibility aims to make advanced medical care available to a wider population.
  • Economic burden: By reducing the cost of medical devices, Openwater can help alleviate the economic burden on healthcare systems and individuals.
  • Global health disparities: The technology’s potential to improve patient outcomes can contribute to addressing global health disparities.

“As a brain tumor survivor, I’m not just developing technology; I’m fighting for my life and the lives of millions like me,” said Mary Lou Jepsen, Openwater’s founder and Chief Executive Officer. “We’ve shrunk brain tumors and treated depression using lower intensity sound waves than fetal ultrasounds.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |